Evidence map›Paper›PMID 37730939›Full record

ArticleCell research2024

Learning human liver biology in humanized mice.

Brandon M Lehrich, Satdarshan P Monga

Abstract readComment
In one paragraph

Article in Cell research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. EpiATLAS - a reference for human epigenomic research.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Brandon M LehrichDivision of Experimental Pathology, Department of Pathology and Pittsburgh Liver Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Satdarshan P MongaDivision of Experimental Pathology, Department of Pathology and Pittsburgh Liver Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. smonga@pitt.edu.ORCID 0000-0002-8437-3378

Funding

Role of Wnt/Beta-Catenin Signaling in Liver DevelopmentR01DK062277 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga · 2004 to 2026
$9.0M
Cellular Approaches to Tissue Engineering/RegenerationT32EB001026 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUNCAN, ANDREW W, MONGA, SATDARSHAN SINGH · 2003 to 2024
$5.5M
Investigating Immunosuppression in Beta-catenin-mutated Hepatocellular Carcinoma for Improved Precision Medicine TherapeuticsF30CA284540 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEHRICH, BRANDON · 2023 to 2025
$161k
NCI NIH HHS F30 CA284540NIBIB NIH HHS T32 EB001026NIDDK NIH HHS R01 DK062277
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HepatocytesLiverAnimalsBiologyHumansMice

Identifiers

PMID37730939
PMCPMC10770126

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.